Cannabis Bioscience International Holdings, Inc. (CBIH) Revenue (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Revenue across 5 years of filings, most recently posting $11205.0 for Q1 2026.

• In Q1 2026, Revenue fell 24.95% year-over-year to $11205.0; the TTM figure through Feb 2026 stood at $123627.0 (down 64.05% YoY), while the FY2025 annual figure was $303022.0, up 21.77% from the prior year.
• Revenue came in at $11205.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $53266.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $178887.0 in Q3 2024 to a low of $11205.0 in Q1 2026.
• Average Revenue over 5 years is $58627.1, with a median of $52259.0 recorded in 2023.
• Year-over-year, Revenue soared 145.65% in 2024 and tumbled 86.47% in 2025.
• Over 5 years, Revenue stood at $82581.0 in 2022, then slipped by 22.81% to $63748.0 in 2023, then grew by 16.47% to $74248.0 in 2024, then slipped by 28.26% to $53266.0 in 2025, then plunged by 78.96% to $11205.0 in 2026.
• Per Business Quant data, the three most recent Revenue figures were $11205.0 in Q1 2026, $53266.0 in Q4 2025, and $24200.0 in Q3 2025.